The stock of Vir Biotechnology Inc (NASDAQ:VIR) last traded at $7.38, up 0.54% from the previous session.
VIR stock price is now -7.82% away from the 50-day moving average and -16.58% away from the 200-day moving average. The market capitalization of the company currently stands at $1.02B.
With the price target reduced from $23 to $9, JP Morgan Downgraded its rating from Overweight to Neutral for Vir Biotechnology Inc (NASDAQ: VIR). On September 08, 2023, BofA Securities Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $23 to quote $14, while ‘JP Morgan’ rates the stock as ‘Overweight’
In other news, de Verneuil Vanina, EVP and General Counsel sold 76 shares of the company’s stock on Dec 02 ’24. The stock was sold for $625 at an average price of $8.22. Upon completion of the transaction, the EVP and General Counsel now directly owns 56,973 shares in the company, valued at $0.42 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 02 ’24, Officer VANINA ALEXANDRA HUARD DE VERN bought 76 shares of the business’s stock. A total of $625 was incurred on buying the stock at an average price of $8.22. A total of 36.32% of the company’s stock is owned by insiders.
During the past 12 months, Vir Biotechnology Inc has had a low of $6.56 and a high of $13.09. As of last week, the company has a debt-to-equity ratio of 0.09, a current ratio of 8.94, and a quick ratio of 8.94. The fifty day moving average price for VIR is $8.0116 and a two-hundred day moving average price translates $8.867375 for the stock.
The latest earnings results from Vir Biotechnology Inc (NASDAQ: VIR) was released for 2024-09-30. The net profit margin was -678.40% and return on equity was -36.58% for VIR. The company reported revenue of $2.38 million for the quarter, compared to $2.64 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -9.81 percent. For the current quarter, analysts expect VIR to generate $9.37M in revenue.
